Mocarski ES, Shenk T, Pass R: Cytomegaloviruses. Fields Virology. Edited by: Knipe D, Howley P. 2007, Lippincott Williams and Wilkins, 2: 2701-2772. Fifth
Google Scholar
Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis MA, Hahn G, Nelson JA, Myers RM, Shenk TE: Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc Natl Acad Sci USA. 2003, 100: 14976-14981. 10.1073/pnas.2136652100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F: Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci USA. 2003, 100: 14223-14228. 10.1073/pnas.2334032100.
Article
PubMed Central
CAS
PubMed
Google Scholar
Miller-Kittrell M, Sparer TE: Feeling manipulated: cytomegalovirus immune manipulation. Virol J. 2009, 6: 4-10.1186/1743-422X-6-4.
Article
PubMed Central
PubMed
CAS
Google Scholar
Sinzger C, Jahn G: Human cytomegalovirus cell tropism and pathogenesis. Intervirology. 1996, 39: 302-319.
CAS
PubMed
Google Scholar
Rubin RH: The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'. Curr Opin Infect Dis. 2007, 20: 399-407. 10.1097/QCO.0b013e328285a358.
Article
PubMed
Google Scholar
van de Berg PJ, Heutinck KM, Raabe R, Minnee RC, Young SL, van Donselaar-van der Pant KA, Bemelman FJ, van Lier RA, ten Berge IJ: Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis. 2010, 202: 690-699. 10.1086/655472.
Article
CAS
PubMed
Google Scholar
Britt W: Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr Top Microbiol Immunol. 2008, 325: 417-470. full_text.
CAS
PubMed
Google Scholar
Decrion AZ, Dichamp I, Varin A, Herbein G: HIV and inflammation. Curr HIV Res. 2005, 3: 243-259. 10.2174/1570162054368057.
Article
CAS
PubMed
Google Scholar
Docke WD, Prosch S, Fietze E, Kimel V, Zuckermann H, Klug C, Syrbe U, Kruger DH, von Baehr R, Volk HD: Cytomegalovirus reactivation and tumour necrosis factor. Lancet. 1994, 343: 268-269. 10.1016/S0140-6736(94)91116-9.
Article
CAS
PubMed
Google Scholar
Docke WD, Kiessling C, Worm M, Friedrich M, Pruss A, Weitz M, Prosch S, Kern F, Volk HD, Sterry W, et al: Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. Br J Dermatol. 2003, 148: 954-963. 10.1046/j.1365-2133.2003.05263.x.
Article
PubMed
Google Scholar
Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G: High incidence of active cytomegalovirus infection among septic patients. Clin Infect Dis. 1998, 26: 1076-1082. 10.1086/520307.
Article
CAS
PubMed
Google Scholar
von Muller L, Klemm A, Durmus N, Weiss M, Suger-Wiedeck H, Schneider M, Hampl W, Mertens T: Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007, 196: 1288-1295. 10.1086/522429.
Article
PubMed
CAS
Google Scholar
Guyotat D, Gibert R, Chomel J, Archimbaud E, Bossard S, Maupas J, Fiere D, Aymard M: Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation. J Med Virol. 1987, 23: 393-399. 10.1002/jmv.1890230412.
Article
CAS
PubMed
Google Scholar
Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB: Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis. 1999, 1: 115-126. 10.1034/j.1399-3062.1999.010205.x.
Article
CAS
PubMed
Google Scholar
Lautenschlager I, Hockerstedt K, Taskinen E, von Willebrand E: Expression of adhesion molecules and their ligands in liver allografts during cytomegalovirus (CMV) infection and acute rejection. Transpl Int. 1996, 9 (Suppl 1): S213-215. 10.1111/j.1432-2277.1996.tb01612.x.
Article
PubMed
Google Scholar
Ricart MJ, Malaise J, Moreno A, Crespo M, Fernandez-Cruz L: Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant. 2005, 20 (Suppl 2): ii25-ii32. 10.1093/ndt/gfh1079. ii62
Article
PubMed
Google Scholar
Kline JN, Hunninghake GM, He B, Monick MM, Hunninghake GW: Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines. Exp Lung Res. 1998, 24: 3-14. 10.3109/01902149809046050.
Article
CAS
PubMed
Google Scholar
Prosch S, Wendt CE, Reinke P, Priemer C, Oppert M, Kruger DH, Volk HD, Docke WD: A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology. 2000, 272: 357-365. 10.1006/viro.2000.0367.
Article
CAS
PubMed
Google Scholar
Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol. 1991, 72 (Pt 9): 2059-2064. 10.1099/0022-1317-72-9-2059.
Article
CAS
PubMed
Google Scholar
Mendelson M, Monard S, Sissons P, Sinclair J: Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol. 1996, 77 (Pt 12): 3099-3102. 10.1099/0022-1317-77-12-3099.
Article
CAS
PubMed
Google Scholar
Soderberg-Naucler C, Fish KN, Nelson JA: Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell. 1997, 91: 119-126. 10.1016/S0092-8674(01)80014-3.
Article
CAS
PubMed
Google Scholar
Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH: Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA. 2005, 102: 4140-4145. 10.1073/pnas.0408994102.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H: Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 2004, 86: 41-44. 10.1111/j.0042-9007.2004.00388.x.
Article
CAS
PubMed
Google Scholar
Ziemann M, Unmack A, Steppat D, Juhl D, Gorg S, Hennig H: The natural course of primary cytomegalovirus infection in blood donors. Vox Sang. 2010, 99: 24-33. 10.1111/j.1423-0410.2009.01306.x.
Article
CAS
PubMed
Google Scholar
Zanghellini F, Boppana SB, Emery VC, Griffiths PD, Pass RF: Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J Infect Dis. 1999, 180: 702-707. 10.1086/314939.
Article
CAS
PubMed
Google Scholar
Kotton CN: Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol. 2010, 6: 711-721. 10.1038/nrneph.2010.141.
Article
PubMed
Google Scholar
Pereyra F, Rubin RH: Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis. 2004, 17: 357-361. 10.1097/01.qco.0000136933.67920.dd.
Article
CAS
PubMed
Google Scholar
Freeman RB: The 'indirect' effects of cytomegalovirus infection. Am J Transplant. 2009, 9: 2453-2458. 10.1111/j.1600-6143.2009.02824.x.
Article
CAS
PubMed
Google Scholar
Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME: Cytomegalovirus in transplantation - challenging the status quo. Clin Transplant. 2007, 21: 149-158. 10.1111/j.1399-0012.2006.00618.x.
Article
PubMed
Google Scholar
Barry SM, Johnson MA, Janossy G: Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant. 2000, 26: 591-597. 10.1038/sj.bmt.1702562.
Article
CAS
PubMed
Google Scholar
Hebart H, Einsele H, Klein R, Fischer I, Buhler S, Dietz K, Jahn G, Berg PA, Kanz L, Muller CA: CMV infection after allogeneic bone marrow transplantation is associated with the occurrence of various autoantibodies and monoclonal gammopathies. Br J Haematol. 1996, 95: 138-144. 10.1046/j.1365-2141.1996.7592380.x.
Article
CAS
PubMed
Google Scholar
Mengarelli A, Minotti C, Palumbo G, Arcieri P, Gentile G, Iori AP, Arcese W, Mandelli F, Avvisati G: High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation. Br J Haematol. 2000, 108: 126-131. 10.1046/j.1365-2141.2000.01812.x.
Article
CAS
PubMed
Google Scholar
Soderberg C, Sumitran-Karuppan S, Ljungman P, Moller E: CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. Transplantation. 1996, 61: 594-600. 10.1097/00007890-199602270-00014.
Article
CAS
PubMed
Google Scholar
Soderberg C, Larsson S, Rozell BL, Sumitran-Karuppan S, Ljungman P, Moller E: Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease. Transplantation. 1996, 61: 600-609. 10.1097/00007890-199602270-00015.
Article
CAS
PubMed
Google Scholar
Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC: Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol. 1997, 5: 104-111. 10.1016/S0966-3274(97)80050-0.
Article
CAS
PubMed
Google Scholar
Varani S, Muratori L, De Ruvo N, Vivarelli M, Lazzarotto T, Gabrielli L, Bianchi FB, Bellusci R, Landini MP: Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol. 2002, 66: 56-62. 10.1002/jmv.2111.
Article
CAS
PubMed
Google Scholar
Fredrich R, Toyoda M, Czer LS, Galfayan K, Galera O, Trento A, Freimark D, Young S, Jordan SC: The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation. 1999, 67: 385-391. 10.1097/00007890-199902150-00008.
Article
CAS
PubMed
Google Scholar
Dubel L, Farges O, Johanet C, Sebagh M, Bismuth H: High incidence of antitissue antibodies in patients experiencing chronic liver allograft rejection. Transplantation. 1998, 65: 1072-1075. 10.1097/00007890-199804270-00011.
Article
CAS
PubMed
Google Scholar
Kantor GL, Goldberg LS, Johnson BL, Derechin MM, Barnett EV: Immunologic abnormalities induced by postperfusion cytomegalovirus infection. Ann Intern Med. 1970, 73: 553-558.
Article
CAS
PubMed
Google Scholar
Wager O, Rasanen JA, Hagman A, Klemola E: Mixed cryoimmunoglobulinaemia in infectious mononucleois and Cytomegalovirus mononucleosis. Int Arch Allergy Appl Immunol. 1968, 34: 345-361. 10.1159/000230129.
Article
CAS
PubMed
Google Scholar
Varani S, Mastroianni A, Frascaroli G, Tammik C, Rahbar A, Christensson M, Rossini G, Landini MP, Soderberg-Naucler C: Generalized Wegener's granulomatosis in an immunocompetent adult after cytomegalovirus mononucleosis and bacterial urinary tract infection. Arthritis Rheum. 2009, 60: 1558-1562. 10.1002/art.24487.
Article
PubMed
Google Scholar
Meyer MF, Hellmich B, Kotterba S, Schatz H: Cytomegalovirus infection in systemic necrotizing vasculitis: causative agent or opportunistic infection?. Rheumatol Int. 2000, 20: 35-38. 10.1007/s002960000063.
Article
CAS
PubMed
Google Scholar
Magro CM, Crowson AN, Ferri C: Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. Hum Pathol. 2007, 38: 42-49. 10.1016/j.humpath.2006.06.002.
Article
CAS
PubMed
Google Scholar
Perez-Mercado AE, Vila-Perez S: Cytomegalovirus as a trigger for systemic lupus erythematosus. J Clin Rheumatol. 2010, 16: 335-337.
PubMed
Google Scholar
Jaeckel E, Manns M, Von Herrath M: Viruses and diabetes. Ann N Y Acad Sci. 2002, 958: 7-25. 10.1111/j.1749-6632.2002.tb02943.x.
Article
PubMed
Google Scholar
Hjelmesaeth J, Sagedal S, Hartmann A, Rollag H, Egeland T, Hagen M, Nordal KP, Jenssen T: Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia. 2004, 47: 1550-1556. 10.1007/s00125-004-1499-z.
Article
CAS
PubMed
Google Scholar
Hjelmesaeth J, Hartmann A, Kofstad J, Stenstrom J, Leivestad T, Egeland T, Fauchald P: Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation. 1997, 64: 979-983. 10.1097/00007890-199710150-00008.
Article
CAS
PubMed
Google Scholar
Burroughs TE, Swindle JP, Salvalaggio PR, Lentine KL, Takemoto SK, Bunnapradist S, Brennan DC, Schnitzler MA: Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients. Transplantation. 2009, 88: 367-373. 10.1097/TP.0b013e3181ae67f0.
Article
PubMed Central
PubMed
Google Scholar
Driscoll CJ, Cashion AK, Hathaway DK, Thompson C, Conley Y, Gaber O, Vera S, Shokouh-Amiri H: Posttransplant diabetes mellitus in liver transplant recipients. Prog Transplant. 2006, 16: 110-116.
Article
PubMed
Google Scholar
Valderhaug TG, Hjelmesaeth J, Rollag H, Leivestad T, Roislien J, Jenssen T, Hartmann A: Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade. Transplantation. 2007, 84: 1125-1130. 10.1097/01.tp.0000287191.45032.38.
Article
PubMed
Google Scholar
Kamalkumar BS, Agarwal SK, Garg P, Dinda A, Tiwari SC: Acute pancreatitis with CMV papillitis and cholangiopathy in a renal transplant recipient. Clin Exp Nephrol. 2009, 13: 389-391. 10.1007/s10157-008-0123-9.
Article
PubMed
Google Scholar
Hjelmesaeth J, Muller F, Jenssen T, Rollag H, Sagedal S, Hartmann A: Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage. Nephrol Dial Transplant. 2005, 20: 2311-2315. 10.1093/ndt/gfi033.
Article
PubMed
Google Scholar
Soderberg-Naucler C, Fish KN, Nelson JA: Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest. 1997, 100: 3154-3163. 10.1172/JCI119871.
Article
PubMed Central
CAS
PubMed
Google Scholar
Goodgame RW: Gastrointestinal cytomegalovirus disease. Ann Intern Med. 1993, 119: 924-935.
Article
CAS
PubMed
Google Scholar
Esclatine A, Lemullois M, Servin AL, Quero AM, Geniteau-Legendre M: Human cytomegalovirus infects Caco-2 intestinal epithelial cells basolaterally regardless of the differentiation state. J Virol. 2000, 74: 513-517. 10.1128/JVI.74.1.513-517.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chiereghin A, Gabrielli L, Zanfi C, Petrisli E, Lauro A, Piccirilli G, Baccolini F, Dazzi A, Cescon M, Morelli MC, et al: Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. Transplant Proc. 2010, 42: 69-73. 10.1016/j.transproceed.2009.12.030.
Article
CAS
PubMed
Google Scholar
Rahbar A, Bostrom L, Lagerstedt U, Magnusson I, Soderberg-Naucler C, Sundqvist VA: Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2003, 9: 154-161. 10.1097/00054725-200305000-00002.
Article
PubMed
Google Scholar
Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A: Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12: 879-884. 10.1097/01.mib.0000231576.11678.57.
Article
PubMed
Google Scholar
Kim JJ, Simpson N, Klipfel N, Debose R, Barr N, Laine L: Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010, 55: 1059-1065. 10.1007/s10620-010-1126-4.
Article
PubMed
Google Scholar
Knosel T, Schewe C, Petersen N, Dietel M, Petersen I: Prevalence of infectious pathogens in Crohn's disease. Pathol Res Pract. 2009, 205: 223-230. 10.1016/j.prp.2008.04.018.
Article
PubMed
CAS
Google Scholar
Kojima T, Watanabe T, Hata K, Shinozaki M, Yokoyama T, Nagawa H: Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol. 2006, 41: 706-711. 10.1080/00365520500408584.
Article
PubMed
Google Scholar
Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I, Rosinach M, Boix J, Cabre E, Gassull MA: Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008, 14: 1373-1379. 10.1002/ibd.20498.
Article
PubMed
Google Scholar
Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, Matsuura M, Ohmori K, Sakurai T, Nagayama S, et al: Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis. 2007, 13: 1516-1521. 10.1002/ibd.20253.
Article
PubMed
Google Scholar
Wada Y, Matsui T, Matake H, Sakurai T, Yamamoto J, Kikuchi Y, Yorioka M, Tsuda S, Yao T, Yao S, et al: Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum. 2003, 46: S59-65. 10.1007/s10350-004-6497-1.
Article
PubMed
Google Scholar
Takahashi Y, Tange T: Prevalence of cytomegalovirus infection in inflammatory bowel disease patients. Dis Colon Rectum. 2004, 47: 722-726. 10.1007/s10350-003-0117-3.
Article
PubMed
Google Scholar
Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, Targan SR, Vasiliauskas EA: Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001, 96: 2137-2142. 10.1111/j.1572-0241.2001.03949.x.
Article
CAS
PubMed
Google Scholar
Minami M, Ohta M, Ohkura T, Ando T, Ohmiya N, Niwa Y, Goto H: Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol. 2007, 13: 754-760.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kuwabara A, Okamoto H, Suda T, Ajioka Y, Hatakeyama K: Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007, 42: 823-829. 10.1007/s00535-007-2103-3.
Article
PubMed
Google Scholar
Kambham N, Vij R, Cartwright CA, Longacre T: Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004, 28: 365-373. 10.1097/00000478-200403000-00009.
Article
PubMed
Google Scholar
Cottone M, Pietrosi G, Martorana G, Casa A, Pecoraro G, Oliva L, Orlando A, Rosselli M, Rizzo A, Pagliaro L: Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001, 96: 773-775. 10.1111/j.1572-0241.2001.03620.x.
Article
CAS
PubMed
Google Scholar
Barahona-Garrido J, Martinez-Benitez B, Espinosa-Cardenas E, Sarti HM, Gutierrez-Manjarrez JI, Aguirre-Gutierrez R, Tellez-Avila FI, Coss-Adame E, Garcia-Juarez I, Yamamoto-Furusho JK: Cytomegalovirus infection in patients who required colectomy for toxic megacolon or severe steroid-refractory ulcerative colitis. Dig Dis Sci. 2010, 55: 867-868. 10.1007/s10620-009-1109-5.
Article
CAS
PubMed
Google Scholar
Maher MM, Nassar MI: Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009, 54: 2456-2462. 10.1007/s10620-008-0639-6.
Article
PubMed
Google Scholar
Criscuoli V, Mocciaro F, Orlando A, Rizzuto MR, Renda MC, Cottone M: Cytomegalovirus disappearance after treatment for refractory ulcerative colitis in 2 patients treated with infliximab and 1 patient with leukapheresis. Inflamm Bowel Dis. 2009, 15: 810-811. 10.1002/ibd.20742.
Article
PubMed
Google Scholar
Matsuoka K, Iwao Y, Mori T, Sakuraba A, Yajima T, Hisamatsu T, Okamoto S, Morohoshi Y, Izumiya M, Ichikawa H, et al: Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007, 102: 331-337. 10.1111/j.1572-0241.2006.00989.x.
Article
PubMed
Google Scholar
Leveque N, Brixi-Benmansour H, Reig T, Renois F, Talmud D, Brodard V, Coste JF, De Champs C, Andreoletti L, Diebold MD: Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. J Med Virol. 2010, 82: 1694-1700. 10.1002/jmv.21877.
Article
PubMed
Google Scholar
Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, Ayyagari A: Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004, 53: 1155-1160. 10.1099/jmm.0.45629-0.
Article
PubMed
Google Scholar
Daniels JA, Lederman HM, Maitra A, Montgomery EA: Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007, 31: 1800-1812. 10.1097/PAS.0b013e3180cab60c.
Article
PubMed
Google Scholar
Raeiszadeh M, Kopycinski J, Paston SJ, Diss T, Lowdell M, Hardy GA, Hislop AD, Workman S, Dodi A, Emery V, et al: The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin Exp Immunol. 2006, 146: 234-242. 10.1111/j.1365-2249.2006.03209.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Mandell BF, Calabrese LH: Infections and systemic vasculitis. Curr Opin Rheumatol. 1998, 10: 51-57. 10.1097/00002281-199801000-00008.
Article
CAS
PubMed
Google Scholar
Mori T, Kameda H, Ogawa H, Iizuka A, Sekiguchi N, Takei H, Nagasawa H, Tokuhira M, Tanaka T, Saito Y, et al: Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy. J Rheumatol. 2004, 31: 1349-1351.
PubMed
Google Scholar
Lidar M, Lipschitz N, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Pagnoux C, Guilpain P, Sinico RA, Radice A, et al: Infectious serologies and autoantibodies in Wegener's granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci. 2009, 1173: 649-657. 10.1111/j.1749-6632.2009.04641.x.
Article
CAS
PubMed
Google Scholar
Lunardi C, Bason C, Corrocher R, Puccetti A: Induction of endothelial cell damage by hCMV molecular mimicry. Trends Immunol. 2005, 26: 19-24. 10.1016/j.it.2004.10.009.
Article
CAS
PubMed
Google Scholar
Namboodiri AM, Rocca KM, Pandey JP: IgG antibodies to human cytomegalovirus late protein UL94 in patients with systemic sclerosis. Autoimmunity. 2004, 37: 241-244. 10.1080/08916930410001710046.
Article
CAS
PubMed
Google Scholar
Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, Puccetti A: Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med. 2000, 6: 1183-1186. 10.1038/80533.
Article
CAS
PubMed
Google Scholar
Lunardi C, Dolcino M, Peterlana D, Bason C, Navone R, Tamassia N, Beri R, Corrocher R, Puccetti A: Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Med. 2006, 3: e2-10.1371/journal.pmed.0030002.
Article
PubMed Central
PubMed
CAS
Google Scholar
Asadullah K, Prosch S, Audring H, Buttnerova I, Volk HD, Sterry W, Docke WD: A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression. Br J Dermatol. 1999, 141: 94-102. 10.1046/j.1365-2133.1999.02926.x.
Article
CAS
PubMed
Google Scholar
Einsele H, Steidle M, Muller CA, Fritz P, Zacher J, Schmidt H, Saal JG: Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis. J Rheumatol. 1992, 19: 677-681.
CAS
PubMed
Google Scholar
Hamerman D, Gresser I, Smith C: Isolation of cytomegalovirus from synovial cells of a patient with rheumatoid arthritis. J Rheumatol. 1982, 9: 658-664.
CAS
PubMed
Google Scholar
Mehraein Y, Lennerz C, Ehlhardt S, Remberger K, Ojak A, Zang KD: Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization. Mod Pathol. 2004, 17: 781-789. 10.1038/modpathol.3800119.
Article
CAS
PubMed
Google Scholar
Murayama T, Jisaki F, Ayata M, Sakamuro D, Hironaka T, Hirai K, Tsuchiya N, Ito K, Furukawa T: Cytomegalovirus genomes demonstrated by polymerase chain reaction in synovial fluid from rheumatoid arthritis patients. Clin Exp Rheumatol. 1992, 10: 161-164.
CAS
PubMed
Google Scholar
Zhang C, Shen K, Jiang Z, He X: Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus. Chin Med J (Engl). 2001, 114: 1309-1312.
CAS
Google Scholar
Nawata M, Seta N, Yamada M, Sekigawa I, Lida N, Hashimoto H: Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus. Scand J Rheumatol. 2001, 30: 360-362. 10.1080/030097401317148570.
Article
CAS
PubMed
Google Scholar
Hayashi T, Lee S, Ogasawara H, Sekigawa I, Iida N, Tomino Y, Hashimoto H, Hirose S: Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection. Lupus. 1998, 7: 561-564. 10.1191/096120398678920596.
Article
CAS
PubMed
Google Scholar
Vasquez V, Barzaga RA, Cunha BA: Cytomegalovirus-induced flare of systemic lupus erythematosus. Heart Lung. 1992, 21: 407-408.
CAS
PubMed
Google Scholar
Sekigawa I, Nawata M, Seta N, Yamada M, Iida N, Hashimoto H: Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2002, 20: 559-564.
CAS
PubMed
Google Scholar
Cunha BA, Gouzhva O, Nausheen S: Severe cytomegalovirus (CMV) community-acquired pneumonia (CAP) precipitating a systemic lupus erythematosus (SLE) flare. Heart Lung. 2009, 38: 249-252. 10.1016/j.hrtlng.2008.07.001.
Article
PubMed
Google Scholar
Su BY, Su CY, Yu SF, Chen CJ: Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol. 2007, 196: 165-170. 10.1007/s00430-007-0040-7.
Article
PubMed
Google Scholar
Barzilai O, Sherer Y, Ram M, Izhaky D, Anaya JM, Shoenfeld Y: Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci. 2007, 1108: 567-577. 10.1196/annals.1422.059.
Article
CAS
PubMed
Google Scholar
Chang M, Pan MR, Chen DY, Lan JL: Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp Immunol. 2006, 143: 167-179. 10.1111/j.1365-2249.2005.02974.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y: Infectious antibodies in systemic lupus erythematosus patients. Lupus. 2009, 18: 1129-1135. 10.1177/0961203309345729.
Article
CAS
PubMed
Google Scholar
Boeckh M, Nichols WG: Immunosuppressive effects of beta-herpesviruses. Herpes. 2003, 10: 12-16.
PubMed
Google Scholar
George MJ, Snydman DR, Werner BG, Griffith J, Falagas ME, Dougherty NN, Rubin RH: The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med. 1997, 103: 106-113. 10.1016/S0002-9343(97)80021-6.
Article
CAS
PubMed
Google Scholar
Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG: Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med. 2005, 143: 870-880.
Article
PubMed
Google Scholar
Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, Vimalachandra D, Craig JC: Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet. 2005, 365: 2105-2115. 10.1016/S0140-6736(05)66553-1.
Article
CAS
PubMed
Google Scholar
Razonable RR, Paya CV: The impact of human herpesvirus-6 and -7 infection on the outcome of liver transplantation. Liver Transpl. 2002, 8: 651-658. 10.1053/jlts.2002.34966.
Article
PubMed
Google Scholar
Razonable RR, Burak KW, van Cruijsen H, Brown RA, Charlton MR, Smith TF, Espy MJ, Kremers W, Wilson JA, Groettum C, et al: The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis. 2002, 35: 974-981. 10.1086/342911.
Article
PubMed
Google Scholar
Franco A, Jimenez L, Sillero C, Trigueros M, Gonzalez D, Alcaraz E, Olivares J: [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience]. Nefrologia. 2010, 30: 669-675.
CAS
PubMed
Google Scholar
Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV: Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis. 1995, 20: 1346-1353. 10.1093/clinids/20.5.1346.
Article
CAS
PubMed
Google Scholar
Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, Dummer S, Ho M: Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis. 1997, 176: 1462-1467. 10.1086/514142.
Article
CAS
PubMed
Google Scholar
Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, et al: Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia. Transplant Proc. 2010, 42: 895-899. 10.1016/j.transproceed.2010.02.042.
Article
CAS
PubMed
Google Scholar
Caillard S, Dharnidharka V, Agodoa L, Bohen E, Abbott K: Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression. Transplantation. 2005, 80: 1233-1243. 10.1097/01.tp.0000179639.98338.39.
Article
CAS
PubMed
Google Scholar
Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F: Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients. Pediatr Transplant. 2009, 13: 54-62. 10.1111/j.1399-3046.2008.00969.x.
Article
CAS
PubMed
Google Scholar
Nichols WG, Corey L, Gooley T, Davis C, Boeckh M: High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002, 185: 273-282. 10.1086/338624.
Article
PubMed
Google Scholar
Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied N, Fernandez Ranada JM, Mandelli F, Kho P, Kennedy L, Bell AR: Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet. 1994, 343: 749-753. 10.1016/S0140-6736(94)91835-X.
Article
CAS
PubMed
Google Scholar
Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C: Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003, 102: 4255-4260. 10.1182/blood-2002-10-3263.
Article
CAS
PubMed
Google Scholar
Boeckh M, Nichols WG: The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood. 2004, 103: 2003-2008. 10.1182/blood-2003-10-3616.
Article
CAS
PubMed
Google Scholar
Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS: The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation. 2002, 74: 576-578. 10.1097/00007890-200208270-00026.
Article
CAS
PubMed
Google Scholar
Snyder LD, Finlen-Copeland CA, Turbyfill WJ, Howell D, Willner DA, Palmer SM: Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med. 181: 1391-1396. 10.1164/rccm.200911-1786OC.
Humar A, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, Matas AJ: Association between cytomegalovirus disease and chronic rejection in kidney transplant recipients. Transplantation. 1999, 68: 1879-1883. 10.1097/00007890-199912270-00011.
Article
CAS
PubMed
Google Scholar
Falagas ME, Snydman DR, Griffith J, Ruthazer R, Werner BG: Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group. Ann Intern Med. 1997, 126: 275-279.
Article
CAS
PubMed
Google Scholar
Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. Jama. 1989, 261: 3561-3566. 10.1001/jama.261.24.3561.
Article
CAS
PubMed
Google Scholar
Hussain T, Burch M, Fenton MJ, Whitmore PM, Rees P, Elliott M, Aurora P: Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Circulation. 2007, 115: 1798-1805. 10.1161/CIRCULATIONAHA.106.627570.
Article
PubMed
Google Scholar
Billingham ME: Histopathology of graft coronary disease. J Heart Lung Transplant. 1992, 11: S38-44.
CAS
PubMed
Google Scholar
Weill D: Role of cytomegalovirus in cardiac allograft vasculopathy. Transpl Infect Dis. 2001, 3 (Suppl 2): 44-48. 10.1034/j.1399-3062.2001.00009.x.
Article
PubMed
Google Scholar
Wu TC, Hruban RH, Ambinder RF, Pizzorno M, Cameron DE, Baumgartner WA, Reitz BA, Hayward GS, Hutchins GM: Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol. 1992, 140: 739-747.
PubMed Central
CAS
PubMed
Google Scholar
Tu W, Potena L, Stepick-Biek P, Liu L, Dionis KY, Luikart H, Fearon WF, Holmes TH, Chin C, Cooke JP, et al: T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation. 2006, 114: 1608-1615. 10.1161/CIRCULATIONAHA.105.607549.
Article
PubMed
Google Scholar
Pouria S, State OI, Wong W, Hendry BM: CMV infection is associated with transplant renal artery stenosis. Qjm. 1998, 91: 185-189. 10.1093/qjmed/91.3.185.
Article
CAS
PubMed
Google Scholar
Chmiel C, Speich R, Hofer M, Michel D, Mertens T, Weder W, Boehler A: Ganciclovir/valganciclovir prophylaxis decreases cytomegalovirus-related events and bronchiolitis obliterans syndrome after lung transplantation. Clin Infect Dis. 2008, 46: 831-839. 10.1086/528689.
Article
PubMed
Google Scholar
Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, et al: Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med. 1999, 340: 1462-1470. 10.1056/NEJM199905133401903.
Article
CAS
PubMed
Google Scholar
Valantine HA, Gao SZ, Menon SG, Renlund DG, Hunt SA, Oyer P, Stinson EB, Brown BW, Merigan TC, Schroeder JS: Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation. 1999, 100: 61-66.
Article
CAS
PubMed
Google Scholar
Fiddian P, Sabin CA, Griffiths PD: Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis. 2002, 186 (Suppl 1): S110-115. 10.1086/342965.
Article
CAS
PubMed
Google Scholar
Slifkin M, Ruthazer R, Freeman R, Bloom J, Fitzmaurice S, Fairchild R, Angelis M, Cooper J, Barefoot L, Rohrer R, et al: Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation. Liver Transpl. 2005, 11: 1597-1602. 10.1002/lt.20523.
Article
PubMed
Google Scholar
Miller W, Flynn P, McCullough J, Balfour HH, Goldman A, Haake R, McGlave P, Ramsay N, Kersey J: Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-v-host disease. Blood. 1986, 67: 1162-1167.
CAS
PubMed
Google Scholar
Ljungman P, Perez-Bercoff L, Jonsson J, Avetisyan G, Sparrelid E, Aschan J, Barkholt L, Larsson K, Winiarski J, Yun Z, et al: Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haematologica. 2006, 91: 78-83.
PubMed
Google Scholar
Cantoni N, Hirsch HH, Khanna N, Gerull S, Buser A, Bucher C, Halter J, Heim D, Tichelli A, Gratwohl A, et al: Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant. 2010, 16: 1309-1314. 10.1016/j.bbmt.2010.03.020.
Article
PubMed
Google Scholar
Matthes-Martin S, Aberle SW, Peters C, Holter W, Popow-Kraupp T, Potschger U, Fritsch G, Ladenstein R, Rosenmayer A, Dieckmann K, et al: CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. Bone Marrow Transplant. 1998, 21 (Suppl 2): S53-56.
PubMed
Google Scholar
Wang LR, Dong LJ, Zhang MJ, Lu DP: Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008, 42: 673-677. 10.1038/bmt.2008.238.
Article
PubMed
Google Scholar
Broers AE, van Der Holt R, van Esser JW, Gratama JW, Henzen-Logmans S, Kuenen-Boumeester V, Lowenberg B, Cornelissen JJ: Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood. 2000, 95: 2240-2245.
CAS
PubMed
Google Scholar
Lonnqvist B, Ringden O, Wahren B, Gahrton G, Lundgren G: Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease. Transplantation. 1984, 38: 465-468. 10.1097/00007890-198411000-00004.
Article
CAS
PubMed
Google Scholar
Larsson K, Aschan J, Remberger M, Ringden O, Winiarski J, Ljungman P: Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus. Transplantation. 2004, 77: 526-531. 10.1097/01.TP.0000109778.39235.F4.
Article
PubMed
Google Scholar
Ljungman P, de La Camara R, Milpied N, Volin L, Russell CA, Crisp A, Webster A: Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. Blood. 2002, 99: 3050-3056. 10.1182/blood.V99.8.3050.
Article
CAS
PubMed
Google Scholar
Michelson S: Consequences of human cytomegalovirus mimicry. Hum Immunol. 2004, 65: 465-475. 10.1016/j.humimm.2004.02.002.
Article
CAS
PubMed
Google Scholar
Hutt-Fletcher LM, Balachandran N, Elkins MH: B cell activation by cytomegalovirus. J Exp Med. 1983, 158: 2171-2176. 10.1084/jem.158.6.2171.
Article
CAS
PubMed
Google Scholar
Varani S, Cederarv M, Feld S, Tammik C, Frascaroli G, Landini MP, Soderberg-Naucler C: Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol. 2007, 179: 7767-7776.
Article
CAS
PubMed
Google Scholar
Homs S, Mansour H, Desvaux D, Diet C, Hazan M, Buchler M, Lebranchu Y, Buob D, Badoual C, Matignon M, et al: Predominant Th1 and cytotoxic phenotype in biopsies from renal transplant recipients with transplant glomerulopathy. Am J Transplant. 2009, 9: 1230-1236. 10.1111/j.1600-6143.2009.02596.x.
Article
CAS
PubMed
Google Scholar
Lamprecht P, Gross WL: Wegener's granulomatosis. Herz. 2004, 29: 47-56. 10.1007/s00059-004-2525-0.
Article
PubMed
Google Scholar
Kobayashi T, Okamoto S, Iwakami Y, Nakazawa A, Hisamatsu T, Chinen H, Kamada N, Imai T, Goto H, Hibi T: Exclusive increase of CX3CR1+CD28-CD4+ T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm Bowel Dis. 2007, 13: 837-846. 10.1002/ibd.20113.
Article
PubMed
Google Scholar
Thewissen M, Linsen L, Somers V, Geusens P, Raus J, Stinissen P: Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients. Ann N Y Acad Sci. 2005, 1051: 255-262. 10.1196/annals.1361.066.
Article
CAS
PubMed
Google Scholar
Fasth AE, Dastmalchi M, Rahbar A, Salomonsson S, Pandya JM, Lindroos E, Nennesmo I, Malmberg KJ, Soderberg-Naucler C, Trollmo C, et al: T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells. J Immunol. 2009, 183: 4792-4799. 10.4049/jimmunol.0803688.
Article
CAS
PubMed
Google Scholar
Thewissen M, Somers V, Hellings N, Fraussen J, Damoiseaux J, Stinissen P: CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol. 2007, 179: 6514-6523.
Article
CAS
PubMed
Google Scholar
Komocsi A, Lamprecht P, Csernok E, Mueller A, Holl-Ulrich K, Seitzer U, Moosig F, Schnabel A, Gross WL: Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol. 2002, 160: 1717-1724. 10.1016/S0002-9440(10)61118-2.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, et al: CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation. 2004, 109: 2744-2748. 10.1161/01.CIR.0000131450.66017.B3.
Article
CAS
PubMed
Google Scholar
van Leeuwen EM, Remmerswaal EB, Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, ten Berge IJ: Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol. 2004, 173: 1834-1841.
Article
CAS
PubMed
Google Scholar
Prosch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Kruger DH: Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. Virology. 1995, 208: 197-206. 10.1006/viro.1995.1143.
Article
CAS
PubMed
Google Scholar
Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE: Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication. Proc Natl Acad Sci USA. 2002, 99: 3932-3937. 10.1073/pnas.052713799.
Article
PubMed Central
CAS
PubMed
Google Scholar
Qiu H, Straat K, Rahbar A, Wan M, Soderberg-Naucler C, Haeggstrom JZ: Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J Exp Med. 2008, 205: 19-24. 10.1084/jem.20070201.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sinzger C, Plachter B, Grefte A, The TH, Jahn G: Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis. 1996, 173: 240-245. 10.1093/infdis/173.1.240.
Article
CAS
PubMed
Google Scholar
Riegler S, Hebart H, Einsele H, Brossart P, Jahn G, Sinzger C: Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol. 2000, 81: 393-399.
Article
CAS
PubMed
Google Scholar
Frascaroli G, Varani S, Blankenhorn N, Pretsch R, Bacher M, Leng L, Bucala R, Landini MP, Mertens T: Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor. J Immunol. 2009, 182: 477-488.
Article
PubMed Central
CAS
PubMed
Google Scholar
Beck K, Meyer-Konig U, Weidmann M, Nern C, Hufert FT: Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur J Immunol. 2003, 33: 1528-1538. 10.1002/eji.200323612.
Article
CAS
PubMed
Google Scholar
Varani S, Frascaroli G, Homman-Loudiyi M, Feld S, Landini MP, Soderberg-Naucler C: Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J Leukoc Biol. 2005, 77: 219-228. 10.1189/jlb.0504301.
Article
CAS
PubMed
Google Scholar
Somer T, Finegold SM: Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis. 1995, 20: 1010-1036. 10.1093/clinids/20.4.1010.
Article
CAS
PubMed
Google Scholar
Rodriguez-Pla A, Stone JH: Vasculitis and systemic infections. Curr Opin Rheumatol. 2006, 18: 39-47. 10.1097/01.bor.0000197999.58073.2e.
Article
PubMed
Google Scholar
Streblow DN, Orloff SL, Nelson JA: Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol. 2007, 19: 577-582. 10.1016/j.coi.2007.07.012.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kahl M, Siegel-Axel D, Stenglein S, Jahn G, Sinzger C: Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J Virol. 2000, 74: 7628-7635. 10.1128/JVI.74.16.7628-7635.2000.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ho DD, Rota TR, Andrews CA, Hirsch MS: Replication of human cytomegalovirus in endothelial cells. J Infect Dis. 1984, 150: 956-957. 10.1093/infdis/150.6.956.
Article
CAS
PubMed
Google Scholar
Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA: Human cytomegalovirus persistently infects aortic endothelial cells. J Virol. 1998, 72: 5661-5668.
PubMed Central
CAS
PubMed
Google Scholar
Shen YH, Zhang L, Utama B, Wang J, Gan Y, Wang X, Wang J, Chen L, Vercellotti GM, Coselli JS, et al: Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res. 2006, 69: 502-511. 10.1016/j.cardiores.2005.10.007.
Article
CAS
PubMed
Google Scholar
Craigen JL, Yong KL, Jordan NJ, MacCormac LP, Westwick J, Akbar AN, Grundy JE: Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration. Immunology. 1997, 92: 138-145. 10.1046/j.1365-2567.1997.00310.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Dengler TJ, Raftery MJ, Werle M, Zimmermann R, Schonrich G: Cytomegalovirus infection of vascular cells induces expression of pro-inflammatory adhesion molecules by paracrine action of secreted interleukin-1beta. Transplantation. 2000, 69: 1160-1168. 10.1097/00007890-200003270-00022.
Article
CAS
PubMed
Google Scholar
Bolovan-Fritts CA, Trout RN, Spector SA: Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells. J Virol. 2004, 78: 13173-13181. 10.1128/JVI.78.23.13173-13181.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bolovan-Fritts CA, Spector SA: Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX3CR1 interaction. Blood. 2008, 111: 175-182. 10.1182/blood-2007-08-107730.
Article
PubMed Central
CAS
PubMed
Google Scholar
Van Dam-Mieras MC, Bruggeman CA, Muller AD, Debie WH, Zwaal RF: Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb Res. 1987, 47: 69-75. 10.1016/0049-3848(87)90241-6.
Article
CAS
PubMed
Google Scholar
Rahbar A, Soderberg-Naucler C: Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation. J Virol. 2005, 79: 2211-2220. 10.1128/JVI.79.4.2211-2220.2005.
Article
PubMed Central
CAS
PubMed
Google Scholar
Goldmacher VS: Cell death suppression by cytomegaloviruses. Apoptosis. 2005, 10: 251-265. 10.1007/s10495-005-0800-z.
Article
CAS
PubMed
Google Scholar
Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE: The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun. 1999, 256: 608-613. 10.1006/bbrc.1999.0387.
Article
CAS
PubMed
Google Scholar
Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E, Ruchti F, Mattison K, Altschuler Y, Nelson JA: The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 1999, 99: 511-520. 10.1016/S0092-8674(00)81539-1.
Article
CAS
PubMed
Google Scholar
Dumortier J, Streblow DN, Moses AV, Jacobs JM, Kreklywich CN, Camp D, Smith RD, Orloff SL, Nelson JA: Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing. J Virol. 2008, 82: 6524-6535. 10.1128/JVI.00502-08.
Article
PubMed Central
CAS
PubMed
Google Scholar
Looney RJ, Falsey A, Campbell D, Torres A, Kolassa J, Brower C, McCann R, Menegus M, McCormick K, Frampton M, et al: Role of cytomegalovirus in the T cell changes seen in elderly individuals. Clin Immunol. 1999, 90: 213-219. 10.1006/clim.1998.4638.
Article
CAS
PubMed
Google Scholar
Naniche D, Oldstone MB: Generalized immunosuppression: how viruses undermine the immune response. Cell Mol Life Sci. 2000, 57: 1399-1407. 10.1007/PL00000625.
Article
CAS
PubMed
Google Scholar
Griffin D: Potential mechanisms of immune suppression. Viral Pathogenesis. Edited by: Nathanson N. 1996, Lippincott-Raven, 207-235.
Google Scholar
Rinaldo CR, Carney WP, Richter BS, Black PH, Hirsch MS: Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis. 1980, 141: 488-495. 10.1093/infdis/141.4.488.
Article
PubMed
Google Scholar
Levin MJ, Rinaldo CR, Leary PL, Zaia JA, Hirsch MS: Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J Infect Dis. 1979, 140: 851-857. 10.1093/infdis/140.6.851.
Article
CAS
PubMed
Google Scholar
Reynolds DW, Dean PH, Pass RF, Alford CA: Specific cell-mediated immunity in children with congenital and neonatal cytomegalovirus infection and their mothers. J Infect Dis. 1979, 140: 493-499. 10.1093/infdis/140.4.493.
Article
CAS
PubMed
Google Scholar
Fiorilli M, Sirianni MC, Iannetti P, Pana A, Divizia M, Aiuti F: Cell-mediated immunity in human cytomegalovirus infection. Infect Immun. 1982, 35: 1162-1164.
PubMed Central
CAS
PubMed
Google Scholar
Kapasi K, Rice GP: Role of the monocyte in cytomegalovirus-mediated immunosuppression in vitro. J Infect Dis. 1986, 154: 881-884. 10.1093/infdis/154.5.881.
Article
CAS
PubMed
Google Scholar
Schrier RD, Oldstone MB: Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity. J Virol. 1986, 59: 127-131.
PubMed Central
CAS
PubMed
Google Scholar
Schrier RD, Rice GP, Oldstone MB: Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis. 1986, 153: 1084-1091. 10.1093/infdis/153.6.1084.
Article
CAS
PubMed
Google Scholar
Simmons P, Kaushansky K, Torok-Storb B: Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA. 1990, 87: 1386-1390. 10.1073/pnas.87.4.1386.
Article
PubMed Central
CAS
PubMed
Google Scholar
Torok-Storb B, Simmons P, Khaira D, Stachel D, Myerson D: Cytomegalovirus and marrow function. Ann Hematol. 1992, 64 (Suppl): A128-131. 10.1007/BF01715365.
Article
PubMed
Google Scholar
Randolph-Habecker J, Iwata M, Torok-Storb B: Cytomegalovirus mediated myelosuppression. J Clin Virol. 2002, 25 (Suppl 2): S51-56. 10.1016/S1386-6532(02)00092-6.
Article
CAS
PubMed
Google Scholar
Frascaroli G, Varani S, Moepps B, Sinzger C, Landini MP, Mertens T: Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment. J Virol. 2006, 80: 7578-7589. 10.1128/JVI.02421-05.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gredmark S, Soderberg-Naucler C: Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J Virol. 2003, 77: 10943-10956. 10.1128/JVI.77.20.10943-10956.2003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gredmark S, Tilburgs T, Soderberg-Naucler C: Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol. 2004, 78: 10378-10389. 10.1128/JVI.78.19.10378-10389.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Hertel L, Lacaille VG, Strobl H, Mellins ED, Mocarski ES: Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003, 77: 7563-7574. 10.1128/JVI.77.13.7563-7574.2003.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lee AW, Hertel L, Louie RK, Burster T, Lacaille V, Pashine A, Abate DA, Mocarski ES, Mellins ED: Human cytomegalovirus alters localization of MHC class II and dendrite morphology in mature Langerhans cells. J Immunol. 2006, 177: 3960-3971.
Article
CAS
PubMed
Google Scholar
Moutaftsi M, Brennan P, Spector SA, Tabi Z: Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J Virol. 2004, 78: 3046-3054. 10.1128/JVI.78.6.3046-3054.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z: Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood. 2002, 99: 2913-2921. 10.1182/blood.V99.8.2913.
Article
CAS
PubMed
Google Scholar
Chang WL, Baumgarth N, Yu D, Barry PA: Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J Virol. 2004, 78: 8720-8731. 10.1128/JVI.78.16.8720-8731.2004.
Article
PubMed Central
CAS
PubMed
Google Scholar
Raftery MJ, Wieland D, Gronewald S, Kraus AA, Giese T, Schonrich G: Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J Immunol. 2004, 173: 3383-3391.
Article
CAS
PubMed
Google Scholar
Razonable RR: Immune-based therapies for cytomegalovirus infection. Immunotherapy. 2010, 2: 117-130. 10.2217/imt.09.82.
Article
CAS
PubMed
Google Scholar
Lux A, Aschermann S, Biburger M, Nimmerjahn F: The pro and anti-inflammatory activities of immunoglobulin G. Ann Rheum Dis. 2010, 69 (Suppl 1): i92-96. 10.1136/ard.2009.117101.
Article
CAS
PubMed
Google Scholar
Lawlor G, Moss AC: Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander?. Inflamm Bowel Dis. 2010, 16: 1620-1627. 10.1002/ibd.21275.
Article
PubMed
Google Scholar
Nakase H, Chiba T: TNF-alpha is an important pathogenic factor contributing to reactivation of cytomegalovirus in inflamed mucosa of colon in patients with ulcerative colitis: lesson from clinical experience. Inflamm Bowel Dis. 2010, 16: 550-551. 10.1002/ibd.21080.
Article
PubMed
Google Scholar
Soderberg-Naucler C: HCMV microinfections in inflammatory diseases and cancer. J Clin Virol. 2008, 41: 218-223. 10.1016/j.jcv.2007.11.009.
Article
PubMed
CAS
Google Scholar